Literature DB >> 24934658

Challenging the gold standard for 3D-QSAR: template CoMFA versus X-ray alignment.

Bernd Wendt1, Richard D Cramer.   

Abstract

X-ray-based alignments of bioactive compounds are commonly used to correlate structural changes with changes in potencies, ultimately leading to three-dimensional quantitative structure-activity relationships such as CoMFA or CoMSIA models that can provide further guidance for the design of new compounds. We have analyzed data sets where the alignment of the compounds is entirely based on experimentally derived ligand poses from X-ray-crystallography. We developed CoMFA and CoMSIA models from these X-ray-determined receptor-bound conformations and compared the results with models generated from ligand-centric Template CoMFA, finding that the fluctuations in the positions and conformations of compounds dominate X-ray-based alignments can yield poorer predictions than those from the self-consistent template CoMFA alignments. Also, when there exist multiple different binding modes, structural interpretation in terms of binding site constraints can often be simpler with template-based alignments than with X-ray-based alignments.

Mesh:

Substances:

Year:  2014        PMID: 24934658     DOI: 10.1007/s10822-014-9761-z

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  32 in total

1.  Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors.

Authors:  Hans Matter; Peter Kotsonis; Otmar Klingler; Hartmut Strobel; Lothar G Fröhlich; Armin Frey; Wolfgang Pfleiderer; Harald H H W Schmidt
Journal:  J Med Chem       Date:  2002-07-04       Impact factor: 7.446

2.  Development of biologically active compounds by combining 3D QSAR and structure-based design methods.

Authors:  Wolfgang Sippl
Journal:  J Comput Aided Mol Des       Date:  2002-11       Impact factor: 3.686

3.  Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.

Authors:  Gang Liu; Zhili Xin; Zhonghua Pei; Philip J Hajduk; Cele Abad-Zapatero; Charles W Hutchins; Hongyu Zhao; Thomas H Lubben; Stephen J Ballaron; Deanna L Haasch; Wiweka Kaszubska; Cristina M Rondinone; James M Trevillyan; Michael R Jirousek
Journal:  J Med Chem       Date:  2003-09-25       Impact factor: 7.446

4.  3D-QSAR illusions.

Authors:  Arthur M Doweyko
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

5.  Partial charge calculation method affects CoMFA QSAR prediction accuracy.

Authors:  Ruchi R Mittal; Lisa Harris; Ross A McKinnon; Michael J Sorich
Journal:  J Chem Inf Model       Date:  2009-03       Impact factor: 4.956

6.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

7.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.

Authors:  Y A Puius; Y Zhao; M Sullivan; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

8.  Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors.

Authors:  Le Wang; Gerard M Sullivan; Laura A Hexamer; Lisa A Hasvold; Reema Thalji; Magdalena Przytulinska; Zhi-Fu Tao; Gaoquan Li; Zehan Chen; Zhan Xiao; Wen-Zhen Gu; John Xue; Mai-Ha Bui; Philip Merta; Peter Kovar; Jennifer J Bouska; Haiying Zhang; Chang Park; Kent D Stewart; Hing L Sham; Thomas J Sowin; Saul H Rosenberg; Nan-Horng Lin
Journal:  J Med Chem       Date:  2007-07-21       Impact factor: 7.446

9.  CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric series.

Authors:  Kelly L Damm-Ganamet; Richard D Smith; James B Dunbar; Jeanne A Stuckey; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2013-05-10       Impact factor: 4.956

10.  Rethinking 3D-QSAR.

Authors:  Richard D Cramer
Journal:  J Comput Aided Mol Des       Date:  2010-11-26       Impact factor: 3.686

View more
  5 in total

1.  Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges.

Authors:  Rama K Mishra; Kristine K Deibler; Matthew R Clutter; Purav P Vagadia; Matthew O'Connor; Gary E Schiltz; Raymond Bergan; Karl A Scheidt
Journal:  J Chem Inf Model       Date:  2019-10-14       Impact factor: 4.956

2.  Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities.

Authors:  Richard D Cramer
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

3.  Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors.

Authors:  Camila Muñoz-Gutiérrez; Daniela Cáceres-Rojas; Francisco Adasme-Carreño; Iván Palomo; Eduardo Fuentes; Julio Caballero
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

4.  Flavonoids as CDK1 Inhibitors: Insights in Their Binding Orientations and Structure-Activity Relationship.

Authors:  Carlos Navarro-Retamal; Julio Caballero
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

5.  Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint Studies.

Authors:  José Luis Velázquez-Libera; Carlos Navarro-Retamal; Julio Caballero
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.